speb/financial-data huggingface dataset:
Financial ratios for GEM.SW — quarterly report dated 2025-12-31
Total revenue: 12184668992.481012
Gross profit: 2501140327.3164554
Operating income: 1623422647.1518986
Net income: 596940774.8481013
Capital expenditures: 357838085.4936709
Net tangible assets: 23352024590.253162
Owner earnings: 239102689.35443038
Return on net tangible assets (%): 1.0239056079712625
Capex to operating income (%): 22.042201155777587
Buffett classification: The Great
Stock price: 15.0126582278481
P/E ratio: 3.9588114740694325
Shares outstanding: 510235966
Book value: 32089432470.151894
P/B ratio: 0.2387078107485665
Market cap (USD): 7659998173.113923
Debt to equity: 1.1952967532971754
Current ratio: 1.0099177046742975
Quick ratio: 0.6625523426231362
Effective tax rate (%): 25.08072955713676
Interest coverage ratio: 4.033972214547448
COGS to revenue (%): 79.4730547964834
R&D to revenue (%): 3.79243501611334
SG&A to revenue (%): -4.7557515279438
Free cash flow (dilution-adjusted): 2295003280.620253
Buyback yield (%): 0
Retained earnings: 9521204028.189873
Inventory turnover: 0.7617340349167326
Receivables turnover: 1.9317427753745586
Capitalized R&D asset: 799233509.2777294
ROCI (R&D-adjusted, %): 2.9738446296632275
Rosenberg metric: 3.3415075342110048
FCF margin (%): 18.835171329122417
Revenue growth (%): 20.86779084341101
Rule of 40 score: 39.70296217253343
Financial ratios for GODREJPROP.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.051958327838587
Shares outstanding: 301225962
Market cap (USD): 6642622361.28709
Buyback yield (%): 0
Retained earnings: -21353026.506659634
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GODREJPROP.NS — annual report dated 2023-03-31
Total revenue: 263875761.2667479
Gross profit: 112611449.45188795
Operating income: 27221680.876979295
Net income: 75590742.99634592
Capital expenditures: 36524969.549330086
Operating cash flow: -348433617.5395859
Depreciation & amortization: 2940316.6869671135
Net tangible assets: 1126393422.6552985
Owner earnings: 42006090.13398296
Return on net tangible assets (%): 3.729255630324979
Capex to operating income (%): 134.17602577296523
Buffett classification: The Gruesome
Stock price: 12.558465286236297
P/E ratio: 50.044961024830805
Shares outstanding: 301225962
Book value: 1131198538.3678439
P/B ratio: 3.3441837650783777
Market cap (USD): 3782935787.0901337
Debt to equity: 0.6924370688931147
Current ratio: 1.4632435718140513
Quick ratio: 0.5874812130426459
Effective tax rate (%): 21.963609843197908
Interest coverage ratio: 3.0119946091644207
COGS to revenue (%): 57.324064585814384
SG&A to revenue (%): 11.813037176540098
Free cash flow (dilution-adjusted): -386192448.2338612
Buyback yield (%): 0
Retained earnings: 49984165.65164434
Inventory turnover: 0.10286083456192953
Receivables turnover: 6.028215259613779
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.398182664924017
FCF margin (%): -146.35389259700335
Rule of 40 score: -146.35389259700335
Financial ratios for GODREJPROP.NS — annual report dated 2024-03-31
Total revenue: 350324979.0142703
Gross profit: 133508814.0064756
Operating income: -20894591.67765919
Net income: 89586281.32869649
Capital expenditures: 83152656.19378823
Operating cash flow: -83051924.69120997
Depreciation & amortization: 5343566.374865091
Net tangible assets: 1196200983.3313346
Owner earnings: 11777191.509773344
Return on net tangible assets (%): 0.9845495593035464
Buffett classification: The Gruesome
Stock price: 27.592370441458733
P/E ratio: 92.7769096653686
Shares outstanding: 301225962
Book value: 1235331574.5293202
P/B ratio: 6.728184158375123
Market cap (USD): 8311538330.088772
Debt to equity: 1.0366803443793724
Current ratio: 1.4275134458387626
Quick ratio: 0.4348740142724291
Effective tax rate (%): 25.293252932529324
COGS to revenue (%): 61.89001013226716
SG&A to revenue (%): 14.77051784100556
Free cash flow (dilution-adjusted): -166895311.18839186
Buyback yield (%): 0
Retained earnings: 136139824.91905504
Inventory turnover: 0.08012676482032492
Receivables turnover: 9.435917312661498
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.340006706185995
FCF margin (%): -47.640140208669926
Revenue growth (%): 32.7613333382797
Rule of 40 score: -14.878806870390228
Financial ratios for GODREJPROP.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1294043239.3693264
Buffett classification: The Gruesome
Stock price: 37.756211180124225
Shares outstanding: 301225962
Book value: 1328055422.8380318
P/B ratio: 8.563762354061886
Market cap (USD): 11373151034.208075
Debt to equity: 1.222272289017923
Current ratio: 1.4028811480861285
Quick ratio: 0.45858249409175156
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GODREJPROP.NS — quarterly report dated 2024-12-31
Total revenue: 112936239.65497144
Gross profit: 57789952.20888215
Operating income: 1149318.1023429304
Net income: 18957920.50355519
Capital expenditures: 0
Depreciation & amortization: 2062011.8894976103
Owner earnings: 21019932.3930528
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 32.480475579904414
P/E ratio: 129.0220952891355
Shares outstanding: 301225962
Market cap (USD): 9783962502.774216
Effective tax rate (%): 28.175792245528015
Interest coverage ratio: 0.23249233671303937
COGS to revenue (%): 48.82957641813228
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GODREJPROP.NS — quarterly report dated 2025-03-31
Total revenue: 248039513.67781153
Gross profit: 90860416.1795651
Operating income: 10391629.646948796
Net income: 44656301.145662844
Capital expenditures: 0
Depreciation & amortization: 2463175.122749591
Net tangible assets: 2021939443.535188
Owner earnings: 47119476.26841243
Return on net tangible assets (%): 2.3304098655906365
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.85237483953787
P/E ratio: 41.90998989484976
Shares outstanding: 301225962
Book value: 2054445873.2756596
P/B ratio: 3.643892796790133
Market cap (USD): 7486180519.02439
Debt to equity: 0.7193350529455048
Current ratio: 1.5145132399019117
Quick ratio: 0.5394425326278055
Effective tax rate (%): 33.24160316116286
Interest coverage ratio: 1.9332318399304045
COGS to revenue (%): 63.36857187295274
Buyback yield (%): 0
Retained earnings: 295614916.9978957
Inventory turnover: 0.040832236484463214
Receivables turnover: 4.89125824150491
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4097066695673537
Revenue growth (%): 119.62791964350023
Rule of 40 score: 119.62791964350023
Financial ratios for GODREJPROP.NS — annual report dated 2025-03-31
Total revenue: 561013560.9071779
Gross profit: 219120879.1208791
Operating income: -2554360.533083937
Net income: 163653261.63198504
Capital expenditures: 24216740.706102405
Operating cash flow: -262144026.18657935
Depreciation & amortization: 8611176.057984568
Net tangible assets: 2021939443.535188
Owner earnings: 148047696.9838672
Return on net tangible assets (%): 7.322063846037767
Buffett classification: The Gruesome
Stock price: 24.85237483953787
P/E ratio: 45.74415715501549
Shares outstanding: 301225962
Book value: 2054445873.2756596
P/B ratio: 3.643892796790133
Market cap (USD): 7486180519.02439
Debt to equity: 0.7193350529455048
Current ratio: 1.5145132399019117
Quick ratio: 0.5394425326278055
Effective tax rate (%): 19.35365896134957
COGS to revenue (%): 60.941963904303265
SG&A to revenue (%): 17.47980270519764
Free cash flow (dilution-adjusted): -287436287.11713815
Buyback yield (%): 0
Retained earnings: 295614916.9978957
Inventory turnover: 0.08881742583590817
Receivables turnover: 11.06300428788787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.10070976184100211
FCF margin (%): -51.23517632128962
Revenue growth (%): 60.14089617181575
Rule of 40 score: 8.905719850526125
Financial ratios for GODREJPROP.NS — quarterly report dated 2025-06-30
Total revenue: 50849520.24338873
Gross profit: 30238708.167563774
Operating income: -31047273.57828224
Net income: 70222326.23449567
Capital expenditures: 0
Depreciation & amortization: 2578984.320149778
Owner earnings: 72801310.55464545
Buffett classification: The Gruesome
Stock price: 27.417505265621344
P/E ratio: 61.70858804915319
Shares outstanding: 301225962
Market cap (USD): 8258864399.2768545
Effective tax rate (%): 30.464692006460837
Interest coverage ratio: -8.116549403487305
COGS to revenue (%): 40.5329528718704
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -79.49942753498573
Rule of 40 score: -79.49942753498573
Financial ratios for GODREJPROP.NS — quarterly report dated 2025-12-31
Total revenue: 55515205.525231145
Gross profit: 38847053.58137462
Operating income: -23873231.59184583
Net income: 21740002.227915786
Capital expenditures: 0
Depreciation & amortization: 3516765.066280495
Owner earnings: 25256767.29419628
Buffett classification: The Gruesome
Stock price: 22.328171995098586
P/E ratio: 43.231612245541555
Shares outstanding: 301225962
Market cap (USD): 6725825088.925031
Effective tax rate (%): 23.885987986337405
Interest coverage ratio: -6.906542056074766
COGS to revenue (%): 30.02448029536881
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 9.17547551974993
Rule of 40 score: 9.17547551974993
Financial ratios for HEAD.L — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 2162162.1621621624
Buffett classification: The Gruesome
Stock price: 0.047567567567567574
Shares outstanding: 80282665
Market cap (USD): 3818851.0918918923
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEAD.L — annual report dated 2022-12-31
Total revenue: 799518072.2891567
Gross profit: 264457831.32530123
Operating income: 45421686.746987954
Net income: 40481927.71084338
Capital expenditures: 15180722.891566265
Operating cash flow: 13132530.120481929
Depreciation & amortization: 24337349.39759036
Net tangible assets: 249397590.36144578
Owner earnings: 49638554.21686748
Return on net tangible assets (%): 19.90338164251208
Capex to operating income (%): 33.42175066312997
Buffett classification: The Good
Stock price: 0.03313253012048193
P/E ratio: 0.06570753831845237
Shares outstanding: 80282665
Book value: 270843373.4939759
P/B ratio: 0.009821055549377226
Market cap (USD): 2659967.8162650606
Debt to equity: 0.16903914590747335
Current ratio: 1.5554231227651967
Quick ratio: 0.7222884386174017
Effective tax rate (%): 19.61722488038278
Interest coverage ratio: 13.464285714285715
COGS to revenue (%): 66.92284508740205
SG&A to revenue (%): 27.245328511151296
Free cash flow (dilution-adjusted): -4578313.253012048
Buyback yield (%): 443.88615694762547
Retained earnings: 220240963.8554217
Inventory turnover: 3.176680972818312
Receivables turnover: 7.975961538461538
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.088191330343797
FCF margin (%): -0.5726341169379143
Rule of 40 score: -0.5726341169379143
Financial ratios for HEAD.L — annual report dated 2023-12-31
Total revenue: 831012658.227848
Gross profit: 263037974.68354428
Operating income: 15063291.139240505
Net income: 9746835.443037974
Capital expenditures: 19113924.05063291
Operating cash flow: 15822784.810126582
Depreciation & amortization: 28354430.379746836
Net tangible assets: 254430379.74683544
Owner earnings: 18987341.772151902
Return on net tangible assets (%): 7.462686567164181
Capex to operating income (%): 126.890756302521
Buffett classification: The Gruesome
Stock price: 0.02645569620253164
P/E ratio: 0.2179100907142857
Shares outstanding: 80282665
Book value: 278987341.7721519
P/B ratio: 0.007613011336206895
Market cap (USD): 2123933.79556962
Debt to equity: 0.426950998185118
Current ratio: 1.4149377593360997
Quick ratio: 0.732883817427386
Effective tax rate (%): -8.450704225352112
Interest coverage ratio: 2.2037037037037037
COGS to revenue (%): 68.34729626808836
SG&A to revenue (%): 29.489718202589494
Free cash flow (dilution-adjusted): -7974683.544303797
Buyback yield (%): 309.9097766014571
Retained earnings: 225443037.97468352
Inventory turnover: 3.4121673003802284
Receivables turnover: 8.237139272271015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.415584415584415
FCF margin (%): -0.9596344249809596
Revenue growth (%): 3.93919625212686
Rule of 40 score: 2.9795618271459006
Financial ratios for HEAD.L — annual report dated 2024-12-31
Total revenue: 657125000
Gross profit: 181750000
Operating income: -42750000
Net income: -31250000
Capital expenditures: 63500000
Operating cash flow: 9500000
Depreciation & amortization: 31375000
Net tangible assets: 216750000
Owner earnings: -63375000
Return on net tangible assets (%): -29.238754325259514
Buffett classification: The Gruesome
Stock price: 0.01775
Shares outstanding: 80282665
Book value: 238750000
P/B ratio: 0.005968658863874345
Market cap (USD): 1425017.30375
Debt to equity: 0.3261780104712042
Current ratio: 1.519792342634653
Quick ratio: 0.8526930564568462
Interest coverage ratio: -4.816901408450704
COGS to revenue (%): 72.3416397184706
SG&A to revenue (%): 34.163971847061056
Free cash flow (dilution-adjusted): -5000000
Buyback yield (%): 0
Retained earnings: 185875000
Inventory turnover: 3.6994163424124515
Receivables turnover: 6.9445178335535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.039408866995073
FCF margin (%): -0.7608902415826517
Revenue growth (%): -20.92479055597867
Rule of 40 score: -21.68568079756132
Financial ratios for HEAD.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 216750000
Buffett classification: The Gruesome
Stock price: 0.01775
Shares outstanding: 80282665
Book value: 238750000
P/B ratio: 0.005968658863874345
Market cap (USD): 1425017.30375
Debt to equity: 0.3261780104712042
Current ratio: 1.519792342634653
Quick ratio: 0.8526930564568462
Buyback yield (%): 0
Retained earnings: 185875000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEAD.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 193424657.5342466
Buffett classification: The Gruesome
Stock price: 0.011917808219178082
Shares outstanding: 80282665
Book value: 211780821.91780823
P/B ratio: 0.004517847254204398
Market cap (USD): 956793.4047945206
Debt to equity: 0.6636481241914618
Current ratio: 1.2609678878335595
Quick ratio: 0.7860696517412935
Buyback yield (%): 0
Retained earnings: 153561643.83561644
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JRSH — annual report dated 2022-03-31
Total revenue: 143354902
Gross profit: 27331635
Operating income: 10488558
Net income: 7919600
Capital expenditures: 5053651
Operating cash flow: 8963545
Depreciation & amortization: 2952475
Net tangible assets: 68804976
Owner earnings: 5818424
Return on net tangible assets (%): 8.456400013859461
Capex to operating income (%): 48.182514698398
Buffett classification: The Good
Stock price: 5.06
P/E ratio: 8.114260366685185
Shares outstanding: 12699940
Book value: 69304258
P/B ratio: 0.927240233926175
Market cap (USD): 64261696.4
Debt to equity: 0.02320801125956792
Current ratio: 4.943070629172596
Quick ratio: 2.944194534440265
Effective tax rate (%): 24.16990819978217
Interest coverage ratio: 49.80889560063825
COGS to revenue (%): 80.93428643270254
SG&A to revenue (%): 11.749215942402863
Free cash flow (dilution-adjusted): 2962815
Buyback yield (%): 0
Retained earnings: 46268110
Inventory turnover: 4.106265509767254
Receivables turnover: 12.549181919361285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.736201671556673
FCF margin (%): 2.066769227047429
Rule of 40 score: 2.066769227047429
Financial ratios for JRSH — annual report dated 2023-03-31
Total revenue: 138063309
Gross profit: 21789740
Operating income: 4414862
Net income: 2419623
Capital expenditures: 5806814
Operating cash flow: 10807134
Depreciation & amortization: 3419912
Net tangible assets: 67734952
Owner earnings: 32721
Return on net tangible assets (%): 0.048307408559173405
Capex to operating income (%): 131.52877711692915
Buffett classification: The Gruesome
Stock price: 3.86
P/E ratio: 20.260085310810815
Shares outstanding: 12699940
Book value: 68234234
P/B ratio: 0.7184336296645464
Market cap (USD): 49021768.4
Debt to equity: 0.011266324173874364
Current ratio: 3.9652826626791566
Quick ratio: 1.704737609440442
Effective tax rate (%): 40.749725802347996
Interest coverage ratio: 5.747537854871109
COGS to revenue (%): 84.21757369294981
SG&A to revenue (%): 12.584717928207848
Free cash flow (dilution-adjusted): 4586420
Buyback yield (%): 2.3847487313411566
Retained earnings: 46172082
Inventory turnover: 3.5604667788820796
Receivables turnover: 59.30274299753878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.373145304416412
FCF margin (%): 3.3219687643441893
Revenue growth (%): -3.691253613357428
Rule of 40 score: -0.36928484901323877
Financial ratios for JRSH — annual report dated 2024-03-31
Total revenue: 117187340
Gross profit: 16902349
Operating income: -664955
Net income: -2005902
Capital expenditures: 4842174
Operating cash flow: 2484541
Depreciation & amortization: 3299500
Net tangible assets: 63887040
Owner earnings: -3548576
Return on net tangible assets (%): -5.554453610622749
Buffett classification: The Gruesome
Stock price: 2.66
Shares outstanding: 12699940
Book value: 64430663
P/B ratio: 0.5243130960797346
Market cap (USD): 33781840.4
Debt to equity: 0.015351448424486956
Current ratio: 3.4453711177319994
Quick ratio: 1.6021276864956586
Interest coverage ratio: -0.552473587482843
COGS to revenue (%): 85.57664249397588
SG&A to revenue (%): 14.990786547420566
Free cash flow (dilution-adjusted): -3343681
Buyback yield (%): 0
Retained earnings: 41704238
Inventory turnover: 3.681321596223537
Receivables turnover: 21.63120605340495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.015719281405588
FCF margin (%): -2.8532783490093725
Revenue growth (%): -15.120577039045182
Rule of 40 score: -17.973855388054556
Financial ratios for JRSH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.71
Shares outstanding: 12699940
Market cap (USD): 34416837.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JRSH — quarterly report dated 2024-12-31
Total revenue: 35384737
Gross profit: 5382790
Operating income: 707727
Net income: 6314
Capital expenditures: 458554
Operating cash flow: -3007895
Depreciation & amortization: 907026
Net tangible assets: 62639718
Owner earnings: 454786
Return on net tangible assets (%): 0.7260345584569841
Capex to operating income (%): 64.79249767212498
Buffett classification: The Good
Stock price: 3.12
P/E ratio: 1568.8871080139372
Shares outstanding: 12699940
Book value: 63183241
P/B ratio: 0.627125360663281
Market cap (USD): 39623812.800000004
Debt to equity: 0.08923206392657192
Current ratio: 3.1340896858445935
Quick ratio: 1.961849798596633
Effective tax rate (%): 98.6154358942872
Interest coverage ratio: 1.939302184748684
COGS to revenue (%): 84.78781967490673
SG&A to revenue (%): 13.2120891558414
Free cash flow (dilution-adjusted): -3940537
Buyback yield (%): 0
Retained earnings: 39164278
Inventory turnover: 1.5692927233009626
Receivables turnover: 4.888772788019385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1140455637484357
FCF margin (%): -11.136261942543193
Rule of 40 score: -11.136261942543193
Financial ratios for JRSH — annual report dated 2025-03-31
Total revenue: 145812006
Gross profit: 22319445
Operating income: 1446843
Net income: -839929
Capital expenditures: 2040596
Operating cash flow: 1364628
Depreciation & amortization: 3273670
Net tangible assets: 62317046
Owner earnings: 393145
Capex to operating income (%): 141.03783202462188
Buffett classification: The Gruesome
Stock price: 3.15
Shares outstanding: 12699940
Book value: 62869109
P/B ratio: 0.6363190386553752
Market cap (USD): 40004811
Debt to equity: 0.08175220043280715
Current ratio: 2.7458923535618003
Quick ratio: 1.3479837547940665
Effective tax rate (%): 655.5416658398979
Interest coverage ratio: 0.8413051821184351
COGS to revenue (%): 84.69299914850633
SG&A to revenue (%): 14.314734823687974
Free cash flow (dilution-adjusted): -2434114
Buyback yield (%): 0
Retained earnings: 38396901
Inventory turnover: 4.457438123873639
Receivables turnover: 47.401982527078346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2908760544952624
FCF margin (%): -1.6693508763606202
Revenue growth (%): 24.42641500353195
Rule of 40 score: 22.75706412717133
Financial ratios for JRSH — quarterly report dated 2025-03-31
Total revenue: 29251426
Gross profit: 5238901
Operating income: 433515
Net income: -144095
Capital expenditures: 963205
Operating cash flow: 1945903
Depreciation & amortization: 857032
Net tangible assets: 62317046
Owner earnings: -250268
Return on net tangible assets (%): -0.4016044021085338
Capex to operating income (%): 222.18493016389283
Buffett classification: The Gruesome
Stock price: 3.15
Shares outstanding: 12699940
Book value: 62869109
P/B ratio: 0.6363190386553752
Market cap (USD): 40004811
Debt to equity: 0.08175220043280715
Current ratio: 2.7458923535618003
Quick ratio: 1.3479837547940665
Effective tax rate (%): 180.18062132399993
Interest coverage ratio: 1.1670287426407049
COGS to revenue (%): 82.09010049629717
SG&A to revenue (%): 16.427869191744705
Free cash flow (dilution-adjusted): 641663
Buyback yield (%): 0
Retained earnings: 38396901
Inventory turnover: 0.8667270604702162
Receivables turnover: 9.50933755169739
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6864111259926017
FCF margin (%): 2.193612714812604
Revenue growth (%): -17.33321064389994
Rule of 40 score: -15.139597929087335
Financial ratios for JRSH — quarterly report dated 2025-06-30
Total revenue: 39629308
Gross profit: 6088880
Operating income: 958996
Net income: 323630
Capital expenditures: 464890
Operating cash flow: -6478515
Depreciation & amortization: 882303
Net tangible assets: 62232958
Owner earnings: 741043
Return on net tangible assets (%): 1.1907565120076729
Capex to operating income (%): 48.476740257519324
Buffett classification: The Good
Stock price: 3.08
P/E ratio: 210.47094792008565
Shares outstanding: 12699940
Book value: 62789975
P/B ratio: 0.6229627452471513
Market cap (USD): 39115815.2
Debt to equity: 0.08445214383347023
Current ratio: 2.845717992163874
Quick ratio: 1.3889551489507526
Effective tax rate (%): 50.39864390569873
Interest coverage ratio: 2.694959645691419
COGS to revenue (%): 84.63541175132303
SG&A to revenue (%): 12.944672160311251
Free cash flow (dilution-adjusted): -7166074
Buyback yield (%): 0
Retained earnings: 38080580
Inventory turnover: 1.2278213594700975
Receivables turnover: 3.971086219769541
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.522525018095738
FCF margin (%): -18.082763393193744
Revenue growth (%): 35.4782088230502
Rule of 40 score: 17.39544542985646
Financial ratios for JRSH — quarterly report dated 2025-09-30
Total revenue: 41968534
Gross profit: 6289680
Operating income: 1089388
Net income: 479303
Capital expenditures: 379511
Operating cash flow: 6796793
Depreciation & amortization: 941212
Net tangible assets: 62271177
Owner earnings: 1041004
Return on net tangible assets (%): 1.6717268729319186
Capex to operating income (%): 34.83708283917208
Buffett classification: The Good
Stock price: 3.17
P/E ratio: 60.52572915664389
Shares outstanding: 12699940
Book value: 62845892
P/B ratio: 0.6405957258113227
Market cap (USD): 40258809.8
Debt to equity: 0.08910970664558314
Current ratio: 2.7258256288510143
Quick ratio: 1.4374818207190223
Effective tax rate (%): 24.287783603108082
Interest coverage ratio: 2.207553669637393
COGS to revenue (%): 85.01334356830286
SG&A to revenue (%): 12.390930786383914
Free cash flow (dilution-adjusted): 6188456
Buyback yield (%): 0
Retained earnings: 37907188
Inventory turnover: 1.3588377755324412
Receivables turnover: 7.2377286293294665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7304214491516396
FCF margin (%): 14.74546621047092
Revenue growth (%): 5.902767719284929
Rule of 40 score: 20.648233929755847
Financial ratios for JRSH — quarterly report dated 2025-12-31
Total revenue: 41769186
Gross profit: 7049161
Operating income: 1942835
Net income: 1170575
Capital expenditures: 92043
Operating cash flow: -3809773
Depreciation & amortization: 902763
Net tangible assets: 63090608
Owner earnings: 1981295
Return on net tangible assets (%): 3.1403961109393657
Capex to operating income (%): 4.7375613472065305
Buffett classification: The Great
Stock price: 2.96
P/E ratio: 20.548570716399194
Shares outstanding: 12699940
Book value: 63651208
P/B ratio: 0.5905908714254096
Market cap (USD): 37591822.4
Debt to equity: 0.15246705137159378
Current ratio: 2.785735519381817
Quick ratio: 1.508380568955175
Effective tax rate (%): 24.136460694242633
Interest coverage ratio: 4.941211627966124
COGS to revenue (%): 83.12353752835882
SG&A to revenue (%): 12.2251029742356
Free cash flow (dilution-adjusted): -4130641
Buyback yield (%): 0
Retained earnings: 38442766
Inventory turnover: 1.3338046080611066
Receivables turnover: 5.333448678697572
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0434670637410015
FCF margin (%): -9.889206363753415
Revenue growth (%): -0.47499395618631807
Rule of 40 score: -10.364200319939732
Financial ratios for LGC.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -17738.970588235294
Operating income: -1393425.7352941176
Net income: -1420355.882352941
Capital expenditures: 2895439.705882353
Operating cash flow: -953399.2647058823
Depreciation & amortization: 17738.970588235294
Net tangible assets: 11031247.058823528
Owner earnings: -4298056.617647058
Return on net tangible assets (%): -38.96256329613419
Buffett classification: The Gruesome
Stock price: 0.22794117647058823
Shares outstanding: 62236883
Book value: 11031247.05882353
P/B ratio: 1.2860149224502375
Market cap (USD): 14186348.330882352
Debt to equity: 0.020707021018369208
Current ratio: 7.628846741404029
Quick ratio: 7.628846741404029
Interest coverage ratio: -42.61240780715956
Free cash flow (dilution-adjusted): -4211068.382352941
Buyback yield (%): 0
Retained earnings: -1420355.882352941
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.422812976145204
Rule of 40 score: 0
Financial ratios for LGC.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -24375
Operating income: -1603144.6969696968
Net income: -1543354.5454545454
Capital expenditures: 4054542.424242424
Operating cash flow: -1309818.9393939392
Depreciation & amortization: 24375
Net tangible assets: 20266875.757575758
Owner earnings: -5573521.969696969
Return on net tangible assets (%): -27.50064704775025
Buffett classification: The Gruesome
Stock price: 0.7272727272727272
Shares outstanding: 62236883
Book value: 20266875.757575758
P/B ratio: 2.2333579273778423
Market cap (USD): 45263187.63636363
Debt to equity: 0.007618529354287463
Current ratio: 18.003572379837767
Quick ratio: 18.003572379837767
Interest coverage ratio: -24.003527676951
Free cash flow (dilution-adjusted): -5573012.121212121
Buyback yield (%): 0
Retained earnings: -3006751.515151515
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.864768781147427
Rule of 40 score: 0
Financial ratios for LGC.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8888888888888886
Shares outstanding: 62236883
Market cap (USD): 117558556.77777776
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LGC.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.5734265734265735
Shares outstanding: 62236883
Market cap (USD): 97925165.55944057
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LGC.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -23093.006993006995
Operating income: -2802790.20979021
Net income: -2565109.79020979
Capital expenditures: 5028015.384615385
Operating cash flow: -1498970.6293706293
Depreciation & amortization: 23093.006993006995
Net tangible assets: 17249988.111888114
Owner earnings: -7570032.167832168
Return on net tangible assets (%): -43.88427469474692
Buffett classification: The Gruesome
Stock price: 1.5734265734265735
Shares outstanding: 62236883
Book value: 17249988.111888114
P/B ratio: 5.676825104125945
Market cap (USD): 97925165.55944057
Debt to equity: 0.006611132558599513
Current ratio: 1.5108924494511051
Quick ratio: 1.5108924494511051
Interest coverage ratio: -85.41996121139789
Free cash flow (dilution-adjusted): -7541360.839160839
Buyback yield (%): 0
Retained earnings: -5340572.7272727275
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.180745188154113
Rule of 40 score: 0
Financial ratios for LGC.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -5557.342657342658
Operating income: -527041.2587412588
Net income: -549972.027972028
Capital expenditures: 1123841.958041958
Operating cash flow: -451042.6573426574
Depreciation & amortization: 5557.342657342658
Net tangible assets: 26599690.20979021
Owner earnings: -1668256.6433566434
Return on net tangible assets (%): -6.271714558324552
Buffett classification: The Gruesome
Stock price: 1.4405594405594406
Shares outstanding: 62236883
Book value: 26599690.20979021
P/B ratio: 3.3705629144374334
Market cap (USD): 89655929.35664336
Debt to equity: 0.0042195401770939184
Current ratio: 9.30294406314227
Quick ratio: 9.30294406314227
Interest coverage ratio: -66.10551705990703
Free cash flow (dilution-adjusted): -1710916.083916084
Buyback yield (%): 0
Retained earnings: -5890544.755244755
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9756396779918264
Rule of 40 score: 0
Financial ratios for LGC.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -5796.350364963503
Operating income: -1151232.8467153283
Net income: -1096764.2335766423
Capital expenditures: 1515995.6204379562
Operating cash flow: -624095.6204379562
Depreciation & amortization: 5796.350364963503
Net tangible assets: 27307845.98540146
Owner earnings: -2606963.5036496352
Return on net tangible assets (%): -9.546573190149438
Buffett classification: The Gruesome
Stock price: 1.4598540145985401
Shares outstanding: 62236883
Book value: 27307845.98540146
P/B ratio: 3.327130362175797
Market cap (USD): 90856763.50364964
Debt to equity: 0.003936544105435968
Current ratio: 8.084997054692101
Quick ratio: 8.084997054692101
Interest coverage ratio: -145.5374181046415
Free cash flow (dilution-adjusted): -2724381.7518248176
Buyback yield (%): 0
Retained earnings: -7245289.05109489
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.203338644664883
Rule of 40 score: 0
Financial ratios for LGC.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -6124.4604316546765
Operating income: -717573.3812949641
Net income: -716493.5251798561
Capital expenditures: 1545943.8848920865
Operating cash flow: -488852.5179856116
Depreciation & amortization: 6124.4604316546765
Net tangible assets: 26428332.374100722
Owner earnings: -2256312.949640288
Return on net tangible assets (%): -8.537477574072867
Buffett classification: The Gruesome
Stock price: 1.496402877697842
Shares outstanding: 62236883
Book value: 26428332.374100722
P/B ratio: 3.52392460870558
Market cap (USD): 93131450.8201439
Debt to equity: 0.0036317847463788453
Current ratio: 5.427151071840697
Quick ratio: 5.427151071840697
Interest coverage ratio: -85.82231973842713
Free cash flow (dilution-adjusted): -2224183.45323741
Buyback yield (%): 0
Retained earnings: -7857533.812949641
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.706665728829937
Rule of 40 score: 0
Financial ratios for LGC.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -5672.262773722628
Operating income: -323095.6204379562
Net income: -285368.6131386861
Capital expenditures: 1838113.8686131386
Operating cash flow: -637591.2408759124
Depreciation & amortization: 5672.262773722628
Net tangible assets: 26301021.897810217
Owner earnings: -2117810.218978102
Return on net tangible assets (%): -8.052197466724392
Buffett classification: The Gruesome
Stock price: 2.503649635036496
Shares outstanding: 62236883
Book value: 26301021.897810217
P/B ratio: 5.924459894150819
Market cap (USD): 155819349.40875912
Debt to equity: 0.003202229104916686
Current ratio: 3.2889383273326525
Quick ratio: 3.2889383273326525
Interest coverage ratio: -41.76646537082468
Free cash flow (dilution-adjusted): -2180114.5985401454
Buyback yield (%): 0
Retained earnings: -8257610.9489051085
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2269768422226772
Rule of 40 score: 0
Financial ratios for LGC.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -23483.211678832115
Operating income: -2752500.729927007
Net income: -2683144.525547445
Capital expenditures: 6095683.211678832
Operating cash flow: -2228472.2627737224
Depreciation & amortization: 23483.211678832115
Net tangible assets: 26301021.897810217
Owner earnings: -8755344.525547445
Return on net tangible assets (%): -33.28898990908183
Buffett classification: The Gruesome
Stock price: 2.503649635036496
Shares outstanding: 62236883
Book value: 26301021.897810217
P/B ratio: 5.924459894150819
Market cap (USD): 155819349.40875912
Debt to equity: 0.003202229104916686
Current ratio: 3.2889383273326525
Quick ratio: 3.2889383273326525
Interest coverage ratio: -84.81805708630424
Free cash flow (dilution-adjusted): -8946996.350364963
Buyback yield (%): 0
Retained earnings: -8257610.9489051085
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.452802329055354
Rule of 40 score: 0
Financial ratios for LIN.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.35227272727273
Shares outstanding: 4870247
Market cap (USD): 191655288.1931818
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIN.PA — annual report dated 2022-12-31
Total revenue: 183695744.68085107
Gross profit: 59494680.85106383
Operating income: 36485106.38297872
Net income: 28146808.5106383
Capital expenditures: 11846808.510638298
Operating cash flow: 51490425.5319149
Depreciation & amortization: 17275531.91489362
Net tangible assets: -100970212.76595746
Owner earnings: 33575531.91489363
Return on net tangible assets (%): -33.25290795684424
Capex to operating income (%): 32.4702589223233
Buffett classification: The Good
Stock price: 45.37234042553192
P/E ratio: 7.8507836779046025
Shares outstanding: 4870247
Book value: 105336170.21276596
P/B ratio: 2.0978027243071824
Market cap (USD): 220974504.84042555
Debt to equity: 1.314535024642482
Current ratio: 0.9888120238296105
Quick ratio: 0.9888120238296105
Effective tax rate (%): 25.314026025347896
Interest coverage ratio: 18.64926590538336
COGS to revenue (%): 67.61237939701402
Free cash flow (dilution-adjusted): 38543617.0212766
Buyback yield (%): 33.063889433854975
Retained earnings: 28146808.5106383
Receivables turnover: 4.603412423353773
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.820512598904967
FCF margin (%): 20.982313492477157
Rule of 40 score: 20.982313492477157
Financial ratios for LIN.PA — annual report dated 2023-12-31
Total revenue: 203655555.55555555
Gross profit: 78190000
Operating income: 42073333.333333336
Net income: 28331111.111111112
Capital expenditures: 9590000
Operating cash flow: 44898888.88888889
Depreciation & amortization: 17851111.111111112
Net tangible assets: -89216666.66666667
Owner earnings: 36592222.222222224
Return on net tangible assets (%): -41.01500716109347
Capex to operating income (%): 22.793535097448895
Buffett classification: The Great
Stock price: 58.93333333333333
P/E ratio: 10.130908341046355
Shares outstanding: 4870247
Book value: 125504444.44444442
P/B ratio: 2.2869300855215404
Market cap (USD): 287019889.8666667
Debt to equity: 1.0631496007224182
Current ratio: 1.0892792587732805
Quick ratio: 1.0892792587732805
Effective tax rate (%): 23.908567336098596
Interest coverage ratio: 8.41653700822405
COGS to revenue (%): 61.606743412079226
Free cash flow (dilution-adjusted): 33730000
Buyback yield (%): 0
Retained earnings: 28331111.111111112
Receivables turnover: 4.696732863549007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.132481818685324
FCF margin (%): 16.562278356702492
Revenue growth (%): 10.865690388953873
Rule of 40 score: 27.427968745656365
Financial ratios for LIN.PA — annual report dated 2024-12-31
Total revenue: 191373958.33333334
Gross profit: 81357291.66666667
Operating income: 41535416.66666667
Net income: 29290625
Capital expenditures: 6975000
Operating cash flow: 51455208.333333336
Depreciation & amortization: 15226041.666666668
Net tangible assets: -64275000
Owner earnings: 37541666.66666667
Return on net tangible assets (%): -58.407882795280706
Capex to operating income (%): 16.792897627526706
Buffett classification: The Great
Stock price: 87.21875000000001
P/E ratio: 14.502143792809134
Shares outstanding: 4870247
Book value: 144166666.6666667
P/B ratio: 2.9464290557080925
Market cap (USD): 424776855.53125006
Debt to equity: 0.7339089595375722
Current ratio: 1.1032726575513188
Quick ratio: 1.1032726575513188
Effective tax rate (%): 25.107198977281808
Interest coverage ratio: 9.455537111690775
COGS to revenue (%): 57.48779385910004
Free cash flow (dilution-adjusted): 44138541.66666667
Buyback yield (%): 0.28299172087187746
Retained earnings: 29290625
Receivables turnover: 7.28147913281281
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.569016097800162
FCF margin (%): 23.064027128386286
Revenue growth (%): -6.030573135468377
Rule of 40 score: 17.03345399291791
Financial ratios for LIN.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -64275000
Buffett classification: The Gruesome
Stock price: 87.21875000000001
Shares outstanding: 4870247
Book value: 144166666.6666667
P/B ratio: 2.9464290557080925
Market cap (USD): 424776855.53125006
Debt to equity: 0.7339089595375722
Current ratio: 1.1032726575513188
Quick ratio: 1.1032726575513188
Buyback yield (%): 0
Retained earnings: 29290625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LST.L — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0029333333333333334
Shares outstanding: 984105500
Market cap (USD): 2886709.466666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LST.L — annual report dated 2022-11-30
Total revenue: 9722344.047619049
Gross profit: 1718296.4285714286
Operating income: -3107498.8095238097
Net income: -2961094.0476190476
Capital expenditures: 159195.2380952381
Operating cash flow: -3277139.285714286
Depreciation & amortization: 378159.52380952385
Net tangible assets: 1053386.9047619049
Owner earnings: -2742129.761904762
Return on net tangible assets (%): -260.3155354892665
Buffett classification: The Gruesome
Stock price: 0.0005952380952380953
Shares outstanding: 984105500
Book value: 2304151.190476191
P/B ratio: 0.2542268431666035
Market cap (USD): 585777.0833333334
Debt to equity: 1.5189985776189658
Current ratio: 1.1421756225669286
Quick ratio: 0.7747115590363471
Interest coverage ratio: -28.936446878325647
COGS to revenue (%): 82.32631533964043
SG&A to revenue (%): 52.204905024251325
Free cash flow (dilution-adjusted): -4625955.952380952
Buyback yield (%): 0
Retained earnings: -3820810.7142857146
Inventory turnover: 4.246315878558676
Receivables turnover: 3.545540229366083
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -94.6598727278793
FCF margin (%): -47.5806650096262
Rule of 40 score: -47.5806650096262
Financial ratios for LST.L — annual report dated 2023-11-30
Total revenue: 11766025.316455696
Gross profit: 2750305.063291139
Operating income: -765246.8354430379
Net income: -1171656.9620253164
Capital expenditures: 9525.316455696202
Operating cash flow: 222236.70886075948
Depreciation & amortization: 428236.70886075945
Net tangible assets: -485534.17721518985
Owner earnings: -752945.5696202533
Buffett classification: The Gruesome
Stock price: 0.0003797468354430379
Shares outstanding: 984105500
Book value: 3123137.9746835446
P/B ratio: 0.11965880226759922
Market cap (USD): 373710.94936708856
Debt to equity: 0.9587424040815813
Current ratio: 1.1090806497724157
Quick ratio: 0.7696994180603289
Interest coverage ratio: -2.166230108536354
COGS to revenue (%): 76.62502850946083
SG&A to revenue (%): 32.559773043175156
Free cash flow (dilution-adjusted): -575231.6455696202
Buyback yield (%): 0
Retained earnings: -5038791.139240506
Inventory turnover: 5.0889070210925
Receivables turnover: 5.422488911653162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.362348502756436
FCF margin (%): -4.888920685604121
Revenue growth (%): 21.020458223108594
Rule of 40 score: 16.131537537504474
Financial ratios for LST.L — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: -468354.43037974683
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 984105500
Book value: 3140506.329113924
P/B ratio: 0.07933135832325676
Market cap (USD): 249140.63291139243
Debt to equity: 0.7775090689238211
Current ratio: 1.234920634920635
Quick ratio: 1.0203703703703706
Buyback yield (%): 0
Retained earnings: -5026582.278481012
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LST.L — annual report dated 2024-11-30
Total revenue: 15236708.860759493
Gross profit: 4612658.227848101
Operating income: 602531.6455696202
Net income: -25316.45569620253
Capital expenditures: 45569.620253164554
Operating cash flow: 1941772.151898734
Depreciation & amortization: 575949.3670886075
Net tangible assets: -468354.43037974683
Owner earnings: 505063.2911392404
Capex to operating income (%): 7.563025210084034
Buffett classification: The Great
Stock price: 0.00025316455696202533
Shares outstanding: 984105500
Book value: 3140506.329113924
P/B ratio: 0.07933135832325676
Market cap (USD): 249140.63291139243
Debt to equity: 0.7775090689238211
Current ratio: 1.234920634920635
Quick ratio: 1.0203703703703706
Interest coverage ratio: 1.2526315789473683
COGS to revenue (%): 69.72667608208025
SG&A to revenue (%): 27.722854531860097
Free cash flow (dilution-adjusted): 1487341.7721518986
Buyback yield (%): 0
Retained earnings: -5026582.278481012
Inventory turnover: 10.348951911220714
Receivables turnover: 5.748328557784145
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.48689138576779
FCF margin (%): 9.761568497133837
Revenue growth (%): 29.497501925733395
Rule of 40 score: 39.25907042286723
Financial ratios for LST.L — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: -718427.027027027
Buffett classification: The Gruesome
Stock price: 0.0005405405405405405
Shares outstanding: 984105500
Book value: 3130133.783783783
P/B ratio: 0.1699444674456968
Market cap (USD): 531948.9189189189
Debt to equity: 0.7481214644568772
Current ratio: 1.1032441369109556
Quick ratio: 0.8794230144573885
Buyback yield (%): 0
Retained earnings: -5622212.162162162
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDICAMEQ.NS — annual report dated 2022-03-31
Total revenue: 15224225.24066992
Gross profit: 6328352.894632732
Operating income: 2505525.5176051697
Net income: 1964618.2249769222
Capital expenditures: 1135197.151523144
Operating cash flow: 541883.1596993274
Depreciation & amortization: 761097.1910853224
Net tangible assets: 19268073.32190426
Owner earnings: 1590518.2645391007
Return on net tangible assets (%): 8.254682437454571
Capex to operating income (%): 45.3077465604177
Buffett classification: The Good
Stock price: 8.38731372807596
P/E ratio: 57.90213233015834
Shares outstanding: 13562815
Book value: 19315534.74878017
P/B ratio: 5.889331355324685
Market cap (USD): 113755584.44085455
Debt to equity: 0.17611765436810478
Current ratio: 1.6926172225371023
Quick ratio: 1.32104750532392
Effective tax rate (%): 17.668611976921543
Interest coverage ratio: 13.565186348707698
COGS to revenue (%): 58.43234848018932
SG&A to revenue (%): 6.687409535078519
Free cash flow (dilution-adjusted): -593313.9918238164
Buyback yield (%): 0
Retained earnings: 9070605.301331926
Inventory turnover: 2.4975249632539422
Receivables turnover: 1.8259871724912413
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.417689361037421
FCF margin (%): -3.8971703482081987
Rule of 40 score: -3.8971703482081987
Financial ratios for MEDICAMEQ.NS — annual report dated 2023-03-31
Total revenue: 17158026.796589527
Gross profit: 6684031.668696712
Operating income: 2300791.7174177836
Net income: 1808051.157125457
Capital expenditures: 804031.6686967114
Operating cash flow: -766479.9025578563
Depreciation & amortization: 775468.940316687
Net tangible assets: 23449013.398294766
Owner earnings: 1779488.4287454328
Return on net tangible assets (%): 7.588756074807133
Capex to operating income (%): 34.94586939834299
Buffett classification: The Good
Stock price: 7.972472594397077
P/E ratio: 59.80426519694693
Shares outstanding: 13562815
Book value: 23558355.663824607
P/B ratio: 4.589843723958078
Market cap (USD): 108129170.8903776
Debt to equity: 0.13292205687175856
Current ratio: 1.978391372534772
Quick ratio: 1.4327284177127044
Effective tax rate (%): 13.590495746553241
Interest coverage ratio: 6.463030759229481
COGS to revenue (%): 61.04428703873288
SG&A to revenue (%): 5.874105719279265
Free cash flow (dilution-adjusted): -1570511.5712545677
Buyback yield (%): 0
Retained earnings: 10053386.11449452
Inventory turnover: 1.9084920756458998
Receivables turnover: 2.1586193897769013
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.640264198203772
FCF margin (%): -9.153217848842242
Revenue growth (%): 12.702134429498981
Rule of 40 score: 3.548916580656739
Financial ratios for MEDICAMEQ.NS — annual report dated 2024-03-31
Total revenue: 21502122.55666147
Gross profit: 8365247.631610504
Operating income: 2087084.7823480032
Net income: 1310828.6365271616
Capital expenditures: 753951.3131070872
Operating cash flow: -808706.0798656914
Depreciation & amortization: 850605.588200024
Net tangible assets: 24486701.043290563
Owner earnings: 1407482.9116200982
Return on net tangible assets (%): 5.7479482807086955
Capex to operating income (%): 36.12461359901633
Buffett classification: The Good
Stock price: 4.581573896353167
P/E ratio: 47.40439553540346
Shares outstanding: 13562815
Book value: 24821249.55030579
P/B ratio: 2.5034613603609515
Market cap (USD): 62139039.16506718
Debt to equity: 0.1503084290410292
Current ratio: 1.8874453908325193
Quick ratio: 1.1852406824401516
Effective tax rate (%): 27.39147725534583
Interest coverage ratio: 3.9580187391976707
COGS to revenue (%): 61.095712250887026
SG&A to revenue (%): 7.952876141483116
Free cash flow (dilution-adjusted): -1562657.3929727785
Buyback yield (%): 0
Retained earnings: 10884674.421393452
Inventory turnover: 1.845019469408103
Receivables turnover: 3.2448148999353954
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.287887936699626
FCF margin (%): -7.267456451589515
Revenue growth (%): 25.3181546547964
Rule of 40 score: 18.050698203206885
Financial ratios for MEDICAMEQ.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 25679813.664596274
Buffett classification: The Gruesome
Stock price: 6.767797419971333
Shares outstanding: 13562815
Book value: 25790109.89010989
P/B ratio: 3.5591311846154134
Market cap (USD): 91790384.36454849
Debt to equity: 0.09340860376407731
Current ratio: 2.278714593244754
Quick ratio: 1.4070227001507338
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDICAMEQ.NS — quarterly report dated 2024-12-31
Total revenue: 5261941.951276372
Gross profit: 2660158.526634806
Operating income: 524035.43536542717
Net income: 340599.1374286047
Capital expenditures: 0
Depreciation & amortization: 257570.81244900337
Owner earnings: 598169.9498776081
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.9553561021098025
P/E ratio: 59.28625779988022
Shares outstanding: 13562815
Market cap (USD): 80771393.07203636
Effective tax rate (%): 24.632447768893474
Interest coverage ratio: 5.919289005924951
COGS to revenue (%): 49.44530838107137
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0